Metropolitan Life Insurance Company (MetLife)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,495
Closed -$5.99K 1216
2024
Q1
$5.99K Buy
+2,495
New +$5.99K ﹤0.01% 2236
2023
Q4
Sell
-4,595
Closed -$5.01K 2372
2023
Q3
$5.01K Hold
4,595
﹤0.01% 2391
2023
Q2
$10.5K Hold
4,595
﹤0.01% 2275
2023
Q1
$11.2K Sell
4,595
-610
-12% -$1.48K ﹤0.01% 2114
2022
Q4
$9.94K Buy
5,205
+111
+2% +$212 ﹤0.01% 2282
2022
Q3
$12.2K Buy
+5,094
New +$12.2K ﹤0.01% 2244
2022
Q1
Sell
-20,131
Closed -$79.3K 2501
2021
Q4
$79.3K Buy
20,131
+760
+4% +$2.99K ﹤0.01% 2595
2021
Q3
$93.2K Buy
+19,371
New +$93.2K ﹤0.01% 2563
2019
Q3
Sell
-15,381
Closed -$96.7K 2601
2019
Q2
$96.7K Hold
15,381
﹤0.01% 2326
2019
Q1
$85.5K Buy
15,381
+621
+4% +$3.45K ﹤0.01% 2400
2018
Q4
$98K Hold
14,760
﹤0.01% 2283
2018
Q3
$157K Hold
14,760
﹤0.01% 2172
2018
Q2
$177K Hold
14,760
﹤0.01% 2025
2018
Q1
$126K Hold
14,760
﹤0.01% 2172
2017
Q4
$146K Sell
14,760
-18,442
-56% -$182K ﹤0.01% 2091
2017
Q3
$408K Hold
33,202
﹤0.01% 1821
2017
Q2
$546K Hold
33,202
﹤0.01% 1626
2017
Q1
$476K Sell
33,202
-922
-3% -$13.2K ﹤0.01% 1680
2016
Q4
$472K Hold
34,124
﹤0.01% 1777
2016
Q3
$617K Hold
34,124
﹤0.01% 1572
2016
Q2
$490K Hold
34,124
﹤0.01% 1720
2016
Q1
$408K Hold
34,124
﹤0.01% 1713
2015
Q4
$454K Buy
34,124
+6,666
+24% +$88.7K ﹤0.01% 1678
2015
Q3
$295K Buy
27,458
+4,697
+21% +$50.5K ﹤0.01% 1994
2015
Q2
$183K Sell
22,761
-4,405
-16% -$35.4K ﹤0.01% 2456
2015
Q1
$180K Buy
27,166
+232
+0.9% +$1.54K ﹤0.01% 2108
2014
Q4
$172K Hold
26,934
﹤0.01% 2512
2014
Q3
$266K Buy
26,934
+12,249
+83% +$121K ﹤0.01% 2175
2014
Q2
$165K Sell
14,685
-11,457
-44% -$129K ﹤0.01% 2619
2014
Q1
$317K Sell
26,142
-842
-3% -$10.2K ﹤0.01% 2126
2013
Q4
$340K Hold
26,984
﹤0.01% 2089
2013
Q3
$448K Buy
26,984
+10,528
+64% +$175K ﹤0.01% 1821
2013
Q2
$250K Buy
+16,456
New +$250K ﹤0.01% 2186